ProCE Banner Activity

Expert Insights on New Data From ASCO 2022 Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

Podcast Episodes
In this podcast episode, listen to Jubilee Brown, MD, and Elisabeth Diver, MD, discuss new data for gynecologic cancers presented at the 2022 ASCO Annual Meeting, including practical insights on how they plan to use the new findings to inform their practice and emerging data for novel agents in endometrial cancers, and practical insights on recent approvals for cervical cancer.

Released: June 30, 2022

Expiration: June 29, 2023

Share

Faculty

Jubilee Brown

Jubilee Brown, MD

Professor and Division Director
Gynecologic Oncology
Levine Cancer Institute, Atrium Health
Charlotte, North Carolina

Elisabeth Diver

Elisabeth Diver, MD

Clinical Assistant Professor
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Stanford University
Stanford Cancer Institute
Stanford University Hospital and Clinics
Stanford, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

GlaxoSmithKline

Karyopharm Therapeutics Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Jubilee Brown, MD

Professor and Division Director
Gynecologic Oncology
Levine Cancer Institute, Atrium Health
Charlotte, North Carolina

Jubilee Brown, MD: funds for research support: Olympus, Tesaro/GlaxoSmithKline.

Elisabeth Diver, MD

Clinical Assistant Professor
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Stanford University
Stanford Cancer Institute
Stanford University Hospital and Clinics
Stanford, California

Elisabeth Diver, MD: consulting fees: EMD Serono, GlaxoSmithKline; funds for research support: Aravive, EMD Serono, GlaxoSmithKline.